Brief: Theradiag, Biosynex Sign Distribution Agreement On AMPLIQUICK SARS-CoV-2 PCR Test

Theradiag SA

13/01/2022 06:32

Jan 13 (Reuters) - Theradiag SA  ALTHE.PA :
    * THERADIAG: SIGNING OF A DISTRIBUTION AGREEMENT WITH
BIOSYNEX OF
THEIR AMPLIQUICK SARS-COV-2 PCR TEST
    * INITIAL TWO-YEAR DISTRIBUTION AGREEMENT WAS SIGNED BETWEEN
THERADIAG AND BIOSYNEX FOR AMPLIQUICK SARS-COV-2 PCR TEST FROM
BIOSYNEX
    * AS AN EXTENSION OF THIS FIRST CONTRACT, BIOSYNEX AND
THERADIAG
INTEND TO EXPLORE POSSIBILITIES OF DEVELOPING JOINT PROJECTS
    * ALREADY ENVISAGED THAT BOARD OF DIRECTORS OF THERADIAG
WILL
INCLUDE A REPRESENTATIVE OF BIOSYNEX WHOSE APPOINTMENT WILL BE
SUBMITTED TO VOTE OF SHAREHOLDERS
    * FOLLOWING ACQUISITION OF SHARES ON MARKET AND ITS
PARTICIPATION
IN THERADIAG'S RIGHTS ISSUE IN NOVEMBER 2021, BIOSYNEX HELD
2,468,932 SHARES ON NOVEMBER 29, 2021, REPRESENTING 18.82% OF
THERADIAG'S CAPITAL

Source text for Eikon:  ID:nBw4HyxxFa 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))